Serum hepcidin/mobilizable iron and serum hepcidin/HIC ratios were 60% and 90% lower in subjects with advanced hepatic fibrosis compared with low-grade fibrosis (Table 1, P = .003 and P = .01, respectively). The gene discussed is HAMP; the disease is fibrosis.